Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants

OBJECTIVE: To analyze reasons for low enrollment in an RCT of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late-preterm newborns. STUDY DESIGN: The original study was a multicenter RCT. Eligibility: ≥34 weeks’ gestation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Perinatol
Autores principales: Watterberg, Kristi L., Fernandez, Erika, Walsh, Michele C., Truog, William E., Stoll, Barbara J., Sokol, Gregory M., Kennedy, Kathleen A., Fraga, Maria V., Beauman, Sandra Sundquist, Carper, Benjamin, Das, Abhik, Duncan, Andrea Freeman, Buss, William F., Gauldin, Cheri, Lacy, Conra Backstrom, Sanchez, Pablo J., Chawla, Sanjay, Lakshminrusimha, Satyan, Cotten, C. Michael, Van Meurs, Krisa P., Poindexter, Brenda B., Bell, Edward F., Carlo, Waldemar A., Devaskar, Uday, Wyckoff, Myra H., Higgins, Rosemary D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688018/
https://ncbi.nlm.nih.gov/pubmed/28880260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2017.131
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares